Catalyst Wire Dossier Catalyst Wire Dossier

Pegylated G-CSF (PEG-G-CSF)

pegylated granulocyte colony-stimulating factor
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Pegylated G-CSF (PEG-G-CSF), covering 2017-02-07 to 2017-02-07. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial of Ara-C, Aclarubicin Combined With PEG-G-CSF for Initial Treatment of AML Patients [Phase 2]

See pricing